American International Group’s Tempest Therapeutics TPST Stock Holding History
Bought
Maintained
Sold
Other funds holding TPST
NMC
GPP
B
AIC
BCM
American International Group's TPST Position: Q2 2020 in Review
American International Group sold out of Tempest Therapeutics (TPST) in Q2 2020, closing a stake of 38 shares — an estimated $39K sold.
American International Group first reported a position in TPST in Q3 2013 and held it in 19 quarters. The position peaked at $451K in Q4 2014. 51 funds tracked by Wall St. Rank hold TPST as of Q2 2020.
- American International Group reported no remaining Tempest Therapeutics position as of Q2 2020 after selling out during the quarter.
- American International Group sold 38 Tempest Therapeutics shares in Q2 2020, an estimated $39K.
- American International Group first reported a position in Tempest Therapeutics in Q3 2013 and held it in 19 quarters.
- American International Group's Tempest Therapeutics position peaked at $451K in Q4 2014.
- 51 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2020.
Based on American International Group's 13F filing for Q2 2020, filed 12 Aug 2020.